Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

MRK Merck and Co Inc

103,40

-0,15 (-0,14%)

07 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

null

Merck (NYSE:MRK)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Merck Charts.

Merck (NYSE:MRK)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Merck Charts.

News Merck and Co Inc

Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
Sonntag 8 Dezember 2024 (4 Stunden vor) • Business Wire

Merck and Ridgeback Biotherapeutics Announce Initiation of Phase 3 Study (MOVe-NOW) Evaluating LAGEVRIO™ (molnupiravir) for the Treatment of COVID-19 in High-Risk Adults
Donnerstag 5 Dezember 2024 (4 Tage vor) • Business Wire

FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations
Dienstag 3 Dezember 2024 (6 Tage vor) • Business Wire

Merck to Participate in the Citi 2024 Global Healthcare Conference
Dienstag 26 November 2024 (2 Wochen vor) • Business Wire

Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis
Montag 25 November 2024 (2 Wochen vor) • Business Wire

Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer
Freitag 22 November 2024 (2 Wochen vor) • Business Wire

Form 8-K - Current report
Freitag 22 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Freitag 22 November 2024 (2 Wochen vor) • Business Wire

Merck’s WELIREG® (belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors
Freitag 22 November 2024 (2 Wochen vor) • Business Wire

Surendralal Karsanbhai Elected to Merck Board of Directors
Freitag 22 November 2024 (2 Wochen vor) • Business Wire

Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities
Donnerstag 21 November 2024 (3 Wochen vor) • Business Wire

Merck Announces First-Quarter 2025 Dividend
Dienstag 19 November 2024 (3 Wochen vor) • Business Wire

Weitere Merck and Co Inc News-Artikel

Deutsche Telekom

Health Care Select Sector

Deutsche Lufthansa

Deutsche Telekom (QX)

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen